To clarify the intrinsic factors involved in the manifestation of adult T-cell leukemidlymphoma (ATL) in Japan, a third nation-wide study on ATL was conducted by the Tand B-cell Malignancy Study Group. General clinico-epidemiological findings on ATL and infectious modes of transmission of human 1-ly
Altered HLA antigens expressed on T and B lymphocytes of adult T-cell leukemia/lymphoma patients and their relatives
β Scribed by Shunro Sonoda; Shinji Yashiki; Kazuo Takahashi; Naomichi Arima; Yasuhisa Daitoku; Makoto Matsumoto; Tadashi Matsumoto; Mitsutoshi Tara; Koichi Shinmyozu; Kaoru Sato; Hidetoshi Inoko; Asako Ando; Kimiyoshi Tsiji
- Publisher
- John Wiley and Sons
- Year
- 1987
- Tongue
- French
- Weight
- 552 KB
- Volume
- 40
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
β¦ Synopsis
The HLA types of peripheral blood lymphocytes (PBL) of 36 adult T-cell leukemidlymphoma (ATLL) patients were examined and compared with those of 45 healthy relatives of these patients, and with those of 10 non-ATLL families including 80 healthy members. Thirty-one percent of ATLL patients showed either a gain or a loss of HLA antigens determined by the presence of alien HLA antigens or the absence of inherent HLA antigens deduced from familial haplotype analysis. The antigen specificity of HLA gained or lost was variable and differed from case to case among ATLL patients. Although the gain of HLA was detected only in ATLL patients, the loss of HLA was found both in ATLL patients and in asymptomatic healthy relatives. The rate of HLA loss in ATLL patients (8.4%) and their relatives (17.8%) was much higher than in relatives of non-ATLL patients ( I . I oh). The HLA gain and loss revealed in the PBL of ATLL patients were confirmed by altered HLA phenotypes in the cloned T and B cells established from ATLL patients. Our results suggest that latently infecting HTLV-I may induce altered HLA phenotypes in T and B cells, primarily with loss of HLA antigens in a population of asymptomatic virus carriers, and secondarily with a gain of HLA antigens after the development of ATLL.
π SIMILAR VOLUMES
## Abstract Serum and peripheral blood cell samples from eleven relatives of a Tβcell leukemia patient with human Tβcell leukemia/lymphoma virus (HTLV)βassociated disease, were investigated for the presence of HTLV antibody and antigen expression. In addition to the patient, three family members we
## BACKGROUND. Attempts were made to clarify the correlation between human Tcell leukemia/lymphoma virus (HTLV-I infection and malignant oncogenicity other than adult T-cell leukemiallymphoma (ATL) in a case-control study. ## METHODS. The occurrence of primary malignant neoplasms (MN) in 110 AT
Using a sandwich enzyme-linked immunosorbent assay (ELISA) we were able to detect a soluble form of the CD30 antigen (CD30s) in the supernatant of cell lines expressing membrane-bound CD30 and in T and B cells after transformation with human T-cell leukemia virus (HTLV-I) and Epstein-Barr-Virus (EBV